Prognostic factors for survival in systemic lupus erythematosus associated pulmonary hypertension (Q33398480)

26 July 2017

title

Prognostic factors for survival in systemic lupus erythematosus associated pulmonary hypertension (English)

1 reference

systemic lupus erythematosus

26 July 2017

main subject

pulmonary hypertension

1 reference

based on heuristic

inferred from title

1 reference

R Fazelzad

3

0 references

author name string

S L Chow

series ordinal

1

1 reference

26 July 2017

V Chandran

series ordinal

2

1 reference

26 July 2017

S R Johnson

series ordinal

4

1 reference

26 July 2017

publication date

29 November 2011

1 reference

26 July 2017

1 reference

26 July 2017

volume

21

1 reference

26 July 2017

issue

4

1 reference

26 July 2017

page(s)

353-364

1 reference

Clinical aspects of pulmonary hypertension in patients with systemic lupus erythematosus and in patients with idiopathic pulmonary arterial hypertension

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0961203311429815

Five-year follow-up study of the prevalence and progression of pulmonary hypertension in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203311429815

Clinical differences between idiopathic and scleroderma-related pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203311429815

Plexogenic arteriopathy associated with pulmonary vasculitis in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203311429815

Pulmonary hypertension in systemic autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203311429815

Epoprostenol for treatment of pulmonary hypertension in patients with systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203311429815

Systemic lupus erythematosus: emerging concepts. Part 1: Renal, neuropsychiatric, cardiovascular, pulmonary, and hematologic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203311429815

Pulmonary hypertension and autoimmune disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203311429815

Evaluation of the quality of prognosis studies in systematic reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203311429815

Plexogenic pulmonary hypertension in systemic lupus erythematosus: Report of two cases and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203311429815

Management of pregnancy in women with pulmonary hypertension secondary to SLE and anti-phospholipid syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203311429815

Pulmonary hypertension, systemic lupus erythematosus, and the contraceptive pill: another report

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203311429815

Bosentan treatment for pulmonary arterial hypertension related to connective tissue disease: a subgroup analysis of the pivotal clinical trials and their open-label extensions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203311429815

Thrombi in antrum atrii dextri of human heart as clinically important source for chronic microembolisation to lungs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203311429815

Factors that prognosticate mortality in idiopathic pulmonary arterial hypertension: A systematic review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203311429815

The pulmonary vasculitides

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203311429815

Cardiovascular manifestations in systemic lupus erythematosus. Prospective study of 100 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203311429815

Outcome of pulmonary vascular disease in pregnancy: a systematic overview from 1978 through 1996.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203311429815

Improvement of severe pulmonary hypertension in a patient with SLE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203311429815

Primary pulmonary hypertension associated with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203311429815

Immunosuppressive therapy in lupus- and mixed connective tissue disease–associated pulmonary arterial hypertension: A retrospective analysis of twenty-three cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203311429815

An update in pulmonary hypertension in systemic lupus erythematosus - do we need to know about it?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203311429815

Endothelin-1 release from cultured endothelial cells induced by sera from patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203311429815

Lupus-associated pulmonary hypertension: long-term response to vasoactive therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203311429815

Treatment of mixed connective tissue disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203311429815

21 January 2018

Identifiers

DOI

10.1177/0961203311429815

1 reference

26 July 2017

1 reference